Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

Asahi Kasei acquires German company Aicuris

 April 21, 2026

Pharmaceutical Technology

Asahi Kasei has completed its acquisition of Aicuris Anti-infective Cures, a German biopharmaceutical company.

M&A / DealsRead full story

Post navigation

Trump executive order lifts psychedelics biotechs →
← Italy leads the way on child genetic disease diagnosis

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com